Axsome Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:AXSM) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 568.5 M596.67 M639.78 M669.25 M689.8 M 負債合計 511.48 M543.47 M566.71 M595.52 M601.51 M 純資産合計 57.02 M53.2 M73.08 M73.73 M88.3 M 負債および純資産合計 568.5 M596.67 M639.78 M669.25 M689.8 M 有利子負債合計 182.13 M183.19 M189.55 M190.14 M190.29 M 純負債 -133.22 M-117.72 M-113.46 M-135.13 M-132.64 M

ニュース

Four Biotech Stocks Near Buy Points As Earnings Season Kicks In

Biotech Stock Knocks At $2 Billion Opportunity, Nears Buy Point

ASML Stock, Astera Labs Among 15 New Stocks On IBD Watchlists

Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists

Axsome Therapeutics Priced For Perfection Ahead Of Auvelity's Alzheimer's Decision (AXSM)

Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists

Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?

Neurocrine Biosciences: The Song Remains The Same (NASDAQ:NBIX)

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?

RBC Capital、Axsome Therapeutics株のOutperform評価を継続

RBC Capital reiterates Axsome Therapeutics stock rating at Outperform

Axsome TherapeuticsがThe Citizens Life Sciences Conferenceで戦略的成長計画を発表